Guardant Health (NASDAQ:GH) Price Target Raised to $55.00 at JPMorgan Chase & Co.
Guardant Health (NASDAQ:GH – Free Report) had its target price upped by JPMorgan Chase & Co. from $50.00 to $55.00 in a report published on Friday morning,Benzinga reports. They currently have an overweight rating on the stock. Several other equities analysts also recently commented on the company. Barclays started coverage on Guardant Health in a […]
Guardant Health (NASDAQ:GH – Free Report) had its target price upped by JPMorgan Chase & Co. from $50.00 to $55.00 in a report published on Friday morning,Benzinga reports. They currently have an overweight rating on the stock. Several other equities analysts also recently commented on the company. Barclays started coverage on Guardant Health in a […]
